Status:
COMPLETED
Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide
Lead Sponsor:
Sanwa Kagaku Kenkyusho Co., Ltd.
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
20-69 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus treated with Biguanide.
Eligibility Criteria
Inclusion
- Type 2 diabetic patients treated with Biguanide
- Criteria for postprandial plasma glucose and HbA1c are met
Exclusion
- Type 1 diabetes
- Patients treated with other antidiabetic drugs or Insulin
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00334399
Last Update
October 10 2008
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
Aichi, Japan
2
Chiba, Japan
3
Fukuoka, Japan
4
Gifu, Japan